Hanshow Technology
301275
Yong Jie New Material
603271
ZZT
873726
4
BEOKA
870199
5
Geovis Insighter Technology
920116
US Stock MarketDetailed Quotes
BPTH Bio-Path Holdings
- 0.178
- +0.010+5.95%
15min DelayClose Mar 11 16:00 ET
1.03MMarket Cap-0.02P/E (TTM)
0.180High0.160Low46.75KVolume0.165Open0.168Pre Close8.05KTurnover0.87%Turnover RatioLossP/E (Static)5.77MShares7.67052wk High-1.45P/B957.01KFloat Cap0.12152wk Low--Dividend TTM5.38MShs Float23999.988Historical High--Div YieldTTM11.91%Amplitude0.121Historical Low0.172Avg Price1Lot Size
Trending Stocks
Discussing
As China's 'two sessions' commence: How will Chinese stocks perform?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Bio-Path Holdings Stock Forum
#pleaseDontScareMe
Bio-Path Holdings Expands Global Patent Portfolio
Thursday, 13th February at 4:01 pm
HOUSTON, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced the receipt of newly issued patents in the United States and New Zealand, and updated investors on th...
Breakthrough Cancer Trial Results: Bio-Path's Dual Success in Solid Tumors and AML Remission
No comment yet